Sept. 10, 2007 - Perceptronix Announces Launch of LungSign(TM)...LungSignTM is a safe, painless and convenient test to assess a patient's risk of lung cancer based on an innovative marker in sputum that is highly correlated with the presence of lung malignancy - even in early stage, presymptomatic disease. As such, LungSignTM is the first test to market that provides both an independent result to help with the early detection of lung cancer and a useful complement to current radiological diagnostic methods.
LungSignTM may benefit high-risk patients of both sexes, in particular: smokers, former smokers, and individuals exposed to industrial and environmental carcinogens. LungSignTM is requested and interpreted under the care of a physician... Perceptronix's Press Release [PDF] -
